Research progress on disability weight for major helminthic diseases

Abstract

Abstract:

The helminthic diseases are caused by helminths that parasitize in mammals, which are receiving inadequate attention due to their prevalence in remote, low-income and resource-constrained countries and regions. In 2010, the World Health Organization listed 17 neglected tropical diseases, of which 8 were helminthic diseases. The impact of these helminthiases is less studied. This paper reviews the prevalence, harmful effects and disability weight of common helminthic diseases, and comprehensively analyzes research methods and applications of the disability weight as well as the problems that exist in these processes.

Key words: Helminthiases, Epidemic status, Disability weight

CLC Number:

R532

Xin-zhong ZANG, Huan-zhang LI, Men-bao QIAN, Hui-hui ZHU, Chang-hai ZHOU, Ying-dan CHEN, Zhi-qiang QIN, Shi-zhu LI. Research progress on disability weight for major helminthic diseases[J]. CHINESE JOURNAL OF PARASITOLOGY AND PARASITIC DISEASES, 2018, 36(5): 510-515.

Figures/Tables 2

References 61

[1]	许隆祺. 图说寄生虫学与寄生虫病[M]. 北京: 北京科学技术出版社, 2016.
[2]	Hotez PJ, Brindley PJ, Bethony JM, et al. Helminth infections: the great neglected tropical diseases[J]. J Clin Invest, 2008, 118(4): 1311-1321.
[3]	Hotez PJ, Molyneux DH, Fenwick A, et al. Control of neglected tropical diseases[J]. N Engl J Med, 2007, 357(10): 1018-1027.
[4]	Lustigman S, Prichard RK, Gazzinelli A, et al. A research agenda for helminth diseases of humans: the problem of helminthiases[J]. PLoS Negl Trop Dis, 2012, 6(4): e1582.
[5]	Fürst T, Salari P, Llamas LM, et al. Global health policy and neglected tropical diseases: then, now, and in the years to come[J]. PLoS Negl Trop Dis, 2017, 11(9): e0005759.
[6]	世界卫生组织. 被忽视的热带病: 全球影响与防治对策[M]. 盛慧锋, 等译. 北京: 人民卫生出版社, 2011.
[7]	钱门宝, 陈颖丹, 周晓农. 重要蠕虫病控制与消除进程中的研究重点[J]. 中国寄生虫学与寄生虫病杂志, 2013, 31(2): 155-159.
[8]	Colley DG, Bustinduy AL, Secor WE, et al. Human schistosomiasis[J]. Lancet, 2014, 383(9936): 2253-2264.
[9]	GBD 2015 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015BD 2015 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015[J]. Lancet, 2016, 388(10053): 1545-1602.
[10]	张利娟, 徐志敏, 钱颖骏, 等. 2016年全国血吸虫病疫情通报[J]. 中国血吸虫病防治杂志, 2017, 29(6): 669-677.
[11]	李伟, 高金亮. 包虫病及其诊断技术概述[J]. 中国卫生检验杂志, 2017, 27(13): 1974-1976.
[12]	McManus DP, Zhang W, Li J, et al. Echinococcosis[J]. Lancet, 2003, 362(9392): 1295-1304.
[13]	Moro P, Schantz PM.Cystic echinococcosis in the Americas[J]. Parasitol Int, 2006, 55(Suppl): S181-S186.
[14]	Oksanen A, Siles-Lucas M, Karamon J, et al. The geographical distribution and prevalence of Echinococcus multilocularis in animals in the European Union and adjacent countries: a systematic review and meta-analysis[J]. Parasit Vectors, 2016, 9(1): 519.
[15]	Massolo A, Liccioli S, Budke C, et al. Echinococcus multilocularis in North America: the great unknown[J]. Parasite, 2014, 21: 73.
[16]	伍卫平, 王虎, 王谦, 等. 2012-2016年中国棘球蚴病抽样调查分析[J]. 中国寄生虫学与寄生虫病杂志, 2018, 36(1): 1-14.
[17]	Kim TS, Pak JH, Kim JB, et al. Clonorchis sinensis, an oriental liver fluke, as a human biological agent of cholangiocarcinoma: a brief review[J]. BMB Rep, 2016, 49(11): 590-597.
[18]	Qian MB, Utzinger J, Keiser J, et al. Clonorchiasis[J]. Lancet, 2016, 387(10020): 800-810.
[19]	汤林华, 许隆祺, 陈颖丹. 中国寄生虫病防治与研究[M]. 北京: 北京科学技术出版社, 2012.
[20]	García HH, Gonzalez AE, Evans CA, et al. Taenia solium cysticercosis[J]. Lancet, 2003, 362(9383): 547-556.
[21]	Del Brutto OH, García HH.Taenia solium cysticercosis: the lessons of history[J]. J Neurol Sci, 2015, 359(1-2): 392-395.
[22]	Sotelo J, Del Brutto OH.Brain cysticercosis[J]. Arch Med Res, 2000, 31(1): 3-14.
[23]	Rizvi SA, Saleh AM, Frimpong H, et al.Neurocysticercosis: a case report and brief review[J]. Asian Pac J Trop Med, 2016, 9(1): 100-102.
[24]	Chen YD, Xu LQ, Zhou XN.Distribution and disease burden of cysticercosis in China[J]. Southeast Asian Trop Med Public Health, 2004, 35: 231-239.
[25]	Jourdan PM, Lamberton PHL, Fenwick A, et al. Soil-transmitted helminth infections[J]. Lancet, 2018, 391(10117): 252-265.
[26]	全国人体重要寄生虫病现状调查办公室. 全国人体重要寄生虫病现状调查报告[J]. 中国寄生虫学与寄生虫病杂志, 2005, 23(5增刊): 332-340.
[27]	陈颖丹, 臧炜. 我国土源性线虫病监测现状及今后监测工作重点[J]. 中国血吸虫病防治杂志, 2015, 27(2): 111-114.
[28]	Khieu V, Or V, Tep C, et al. How elimination of lymphatic filariasis as a public health problem in the Kingdom of Cambodia was achieved[J]. Infect Dis Poverty, 2018, 7: 15.
[29]	Sudomo M, Chayabejara S, Duong S, et al. Elimination of lymphatic filariasis in Southeast Asia[J]. Adv Parasitol, 2010, 72: 205-233.
[30]	陈海宁. 我国淋巴丝虫病流行病学调查和防治对策研究概述[J]. 中国热带医学, 2009, 9(10): 2062-2063.
[31]	方博, 靳文正, 宋桂香. 疾病负担研究进展[J]. 现代预防医学, 2009, 36(9): 1665-1668.
[32]	Anand S, Hanson K.Disability-adjusted life years: a critical review[J]. J Health Econ, 1997, 16(6): 685-702.
[33]	Mont D.Measuring health and disability[J]. Lancet, 2007, 369(9573): 1658-1663.
[34]	Salomon JA, Vos T, Hogan DR, et al. Common values in assessing health outcomes from disease and injury: disability weights measurement study for the global burden of disease Study 2010[J]. Lancet, 2012, 380(9859): 2129-2143.
[35]	Haagsma JA, Polinder S, Cassini A, et al. Review of disability weight studies: comparison of methodological choices and values[J]. Popul Health Metr, 2014, 12: 20.
[36]	Ock M, Lee JY, Oh IH, et al. Disability weights measurement for 228 causes of disease in the Korean burden of disease study 2012[J]. J Korean Med Sci, 2016, 31(Suppl 2): S129-S138.
[37]	贾铁武, 周晓农. 疾病负担(DALY)的评价与应用[J]. 中国寄生虫学与寄生虫病杂志, 2005, 23(5): 304-308.
[38]	Finkelstein JL, Schleinitz MD, Carabin H, et al. Decision-model estimation of the age-specific disability weight for schistosomiasis japonica: a systematic review of the literature[J]. PLoS Negl Trop Dis, 2008, 2(3): e158.
[39]	King CH, Dickman K, Tisch DJ.Reassessment of the cost of chronic helmintic infection: a meta-analysis of disability-related outcomes in endemic schistosomiasis[J]. Lancet, 2005, 365(9470): 1561-1569.
[40]	Qian MB, Chen YD, Fang YY, et al. Disability weight of Clonorchis sinensis infection: captured from community study and model simulation[J]. PLoS Negl Trop Dis, 2011, 5(12): e1377.
[41]	World Health Organization.Global burden of disease 2004 updata: disability weights for diseases and conditions[R]. Geneva: World Health Organization. 2004.
[42]	Jia TW, Zhou XN, Wang XH, et al. Assessment of the age-specific disability weight of chronic schistosomiasis japonica[J]. Bull World Health Organ, 2007, 85(6): 458-465.
[43]	许毅从, 邹先胜, 赵焕虎, 等. 湖区慢性血吸虫病伤残权重的初步探讨[J]. 中国寄生虫学与寄生虫病杂志, 2009, 27(4): 303-306.
[44]	Jia TW, Utzinger J, Deng Y, et al. Quantifying quality of life and disability of patients with advanced schistosomiasis japonica[J]. PLoS Negl Trop Dis, 2011, 5(2): e966.
[45]	邓瑶. 晚期血吸虫病疾病负担与患者生命质量研究[D]. 北京: 中国疾病预防控制中心, 2008.
[46]	尚煜. 我国儿童主要土源性线虫病疾病负担研究[D]: 北京:中国疾病预防控制中心, 2011.
[47]	张梦媛, 伍卫平, 官亚宜, 等. 我国棘球蚴病疾病负担分析[J]. 中国寄生虫学与寄生虫病杂志, 2018, 36(1): 15-19, 25.
[48]	张奕, 张旭东,钟波,等. 四川省血吸虫病疾病负担评价[J]. 预防医学情报杂志, 2011, 27(4): 271-273.
[49]	Altintas N. Cystic and alveolar echinococcosis in Turkey[J]. Ann Trop Med Parasitol, 1998, 92(6): 637-642.
[50]	Budke CM, Jiamin Q, Zinsstag J, et al. Use of disability adjusted life years in the estimation of the disease burden of echinococcosis for a high endemic region of the Tibetan plateau[J]. Am J Trop Med Hyg, 2004, 71(1): 56-64.
[51]	Salomon JA, Wang H, Freeman MK, et al. Healthy life expectancy for 187 countries, 1990-2010: a systematic analysis for the global burden disease study 2010[J]. Lancet, 2012, 380(9859): 2144-2162.
[52]	Pullan RL, Smith JL, Jasrasaria R, et al. Global numbers of infection and disease burden of soil transmitted helminth infections in 2010[J]. Parasit Vectors, 2014, 7: 37.
[53]	Bhattarai R, Budke CM, Carabin H, et al. Quality of life in patients with neurocysticercosis in Mexico[J]. Am J Trop Med Hyg, 2011, 84(5): 782-786.
[54]	Wallin MT, Pretell EJ, Bustos JA, et al. Cognitive changes and quality of life in neurocysticercosis: a longitudinal study[J]. PLoS Negl Trop Dis, 2012, 6(1): e1493.
[55]	Praet N, Speybroeck N, Manzanedo R, et al. The disease burden of Taenia solium cysticercosis in Cameroon[J]. PLoS Negl Trop Dis, 2009, 3(3): e406.
[56]	Bhattarai R, Budke CM, Carabin H, et al. Estimating the non-monetary burden of neurocysticercosis in Mexico[J]. PLoS Negl Trop Dis, 2012, 6(2): e1521.
[57]	Croker C, Redelings M, Reporter R, et al. The impact of neurocysticercosis in California: a review of hospitalized cases[J]. PLoS Negl Trop Dis, 2012, 6(1): e1480.
[58]	Rajkotia Y, Lescano AG, Gilman RH, et al. Economic burden of neurocysticercosis: results from Peru[J]. Trans R Soc Trop Med Hyg, 2007, 101(8): 840-846.
[59]	Croker C, Reporter R, Mascola L.Use of statewide hospital discharge data to evaluate the economic burden of neurocysticercosis in Los Angeles County (1991-2008)[J]. Am J Trop Med Hyg, 2010, 83(1): 106-110.
[60]	O′Keefe KA, Eberhard ML, Shafir SC, et al. Cysticercosis-related hospitalizations in the United States, 1998-2011[J]. Am J Trop Med Hyg, 2015, 92(2): 354-359.
[61]	Carabin H, Ndimubanzi PC, Budke CM, et al. Clinical manifestations associated with neurocysticercosis: a systematic review[J]. PLoS Negl Trop Dis, 2011, 5(5): e1152.

重点蠕虫病	伤残权重
重点蠕虫病	GBD 2004^[41]	韩国的研究^[36]	其他学者的研究
血吸虫病	0.104	0.34	0.02~0.15^[39]
慢性血吸虫病	-	-	0.192^[42] 0.122^[43]
晚期血吸虫病	-	-	0.447^[44] 0.442^[45]
囊尾蚴病	-	0.471	-
土源性蠕虫病
蛔虫病	0.060 0.463 0.024	0.256	0.109^[46]
鞭虫病	0.006 0.116 0.024	0.320	0.116^[46]
钩虫病	0.006 0.024 0.024	0.302	0.119^[46]
棘球蚴病	-	0.354	0.302^[47]
细粒棘球蚴病	-	-	-
多房棘球蚴病	-	-	-
华支睾吸虫病	-	-	0.101（男）^[40] 0.005（女）^[40]